Market Research Logo

Obstructive Sleep Apnea (OSA)- Epidemiology Forecast to 2027

DelveInsight’s ‘Obstructive Sleep Apnea (OSA)- Epidemiology Forecast to 2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Obstructive Sleep Apnea in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Geography Covered

• The United States
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan

Study Period: 2016-2027

Obstructive Sleep Apnea Epidemiology

The Obstructive Sleep Apnea (OSA) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for Obstructive Sleep Apnea are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Obstructive Sleep Apnea Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Prevalent cases by Age Group, Total Adult Prevalent cases, Gender Specific Prevalent Cases, Severity Specific Prevalent Cases and Prevalence of Clinical Manifestations of OSA) scenario of Obstructive Sleep Apnea (OSA) in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.
The DelveInsight report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
According to DelveInsight, the total number of adult prevalent population of Obstructive Sleep Apnea (OSA) in 7 MM was found to be 1,381,527, in the year 2016.

Report Scope

• The report covers detailed overview of Obstructive Sleep Apnea explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The report provides the insight about the historical and forecasted patient pool of Obstructive Sleep Apnea in 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Report assesses the disease risk and burden and highlights the unmet needs of the disease
• The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
• The report provides the segmentation of the disease epidemiology by age group with primary focus on the Adult (18-65 years) age group as the target population in 7MM and further segments based on total prevalence, severity, gender and clinical manifestations.

Key strengths

• 10 Year Forecast of Obstructive Sleep Apnea epidemiology
• 7MM Coverage
• Total Prevalent Cases of OSA
• Prevalent Cases according to segmentation: Age Group specific prevalence i.e., Adult Population with further segments based on Gender, Severity and Clinical Manifestations.

Key assessments

• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population


1. Key Insights
2. Obstructive Sleep Apnea (OSA) Market Overview at a Glance
2.1. Market Share (%) Distribution of OSA in 2016
2.2. Market Share (%) Distribution of OSA in 2027
3. Obstructive Sleep Apnea (OSA): Disease Overview
3.1. Introduction
3.2. Severity Based Classification
3.3. Clinical Manifestations of Obstructive Sleep Apnea
3.4. Etiology
3.5. Risk Factors
3.6. Signs and Symptoms
3.7. Pathogenesis of Obstructive Sleep Apnea
3.8. Diagnosis
3.9. Diagnostic Criteria for OSAS
3.10. Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Population and Forecast Parameters
4.3. Prevalence of OSA by Age Group in 7MM
4.4. Total Prevalence of OSA in Adults in 7MM
5. Country Wise-Epidemiology of Obstructive Sleep Apnea
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalence of OSA by Age Group in the United States
5.1.3. Prevalence of OSA in Adults in the US
5.2. EU5 Countries
5.2.1. Germany
5.2.2. Prevalence of OSA by Age Group in Germany
5.2.3. Prevalence of OSA in Adults in Germany
5.3. France
5.3.1. Prevalence of OSA by Age Group in France
5.3.2. Prevalence of OSA in Adults in France
5.4. Italy
5.4.1. Prevalence of OSA by Age Group in Italy
5.4.2. Prevalence of OSA in Adults in Italy
5.5. Spain
5.5.1. Prevalence of OSA by Age Group in Spain
5.5.2. Prevalence of OSA in Adults in Spain
5.6. United Kingdom
5.6.1. Prevalence of OSA by Age Group in the United Kingdom
5.6.2. Prevalence of OSA in Adults in the United Kingdom
5.7. Japan
5.7.1. Prevalence of OSA by Age Group in Japan
5.7.2. Prevalence of OSA in Adults in Japan
6. Unmet Needs
7. Market Drivers
8. Market Barriers
9. Appendix
9.1. Report Methodology
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
List of Tables and Figures
Table 1: Prevalent Population of Obstructive Sleep Apnea in the 7MM (2016-2027)
Table 2: Total Adult Cases of Obstructive Sleep Apnea in the 7MM (2016-2027)
Table 3: Gender-specific Prevalent Cases of Obstructive Sleep Apnea in the United States (2016-2027)
Table 4: Prevalence of OSA in Adults in the United States (2016-2027)
Table 5: Gender Specific Prevalence of Obstructive Sleep Apnea in the United States (2016-2027)
Table 6: Severity-specific Prevalent Cases of Obstructive Sleep Apnea in the United States (2016-2027)
Table 7: Prevalence of Clinical Manifestation of OSA in Adults in the United States (2016-2027)
Table 8: Prevalence of Obstructive Sleep Apnea in Germany by Age Group (2016-2027)
Table 9: Total Prevalence of Obstructive Sleep Apnea in Adults in Germany (2016-2027)
Table 10: Gender Specific Prevalence of Obstructive Sleep Apnea in Adults in Germany (2016-2027)
Table 11: Severity specific prevalent cases of Obstructive Sleep Apnea in Germany (2016-2027)
Table 12: Prevalence of Clinical Manifestation of OSA in Adults in Germany (2016-2027)
Table 13: Age Specific Prevalence of Obstructive Sleep Apnea in France (2016-2027)
Table 14: Total Prevalence of Obstructive Sleep Apnea in France (2016-2027)
Table 15: Gender-specific Prevalent Cases of Obstructive Sleep Apnea in France (2016-2027)
Table 16: Severity Specific Prevalence of Obstructive Sleep Apnea in France (2016-2027)
Table 17: Prevalence of Clinical Manifestation of OSA in Adults in France (2016-2027)
Table 18: Prevalent Cases of Obstructive Sleep Apnea By Age Group in Italy (2016-2027)
Table 19: Prevalent Cases of Obstructive Sleep Apnea By Age Group in Italy (2016-2027)
Table 20: Total Prevalence of Obstructive Sleep Apnea in Adults in Italy (2016-2027)
Table 21: Total Prevalence of Obstructive Sleep Apnea in Adults in Italy (2016-2027)
Table 22: Gender-specific Prevalence of Obstructive Sleep Apnea in Italy (2016-2027)
Table 23: Gender-specific Prevalence of Obstructive Sleep Apnea in Italy (2016-2027)
Table 24: Severity specific Prevalent Cases of Obstructive Sleep Apnea in Italy (2016-2027)
Table 25: Severity specific Prevalent Cases of Obstructive Sleep Apnea in Italy (2016-2027)
Table 26: Prevalence of Clinical Manifestation of OSA in Adults in Italy (2016-2027)
Table 27: Prevalence of Clinical Manifestation of OSA in Adults in Italy (2016-2027)
Table 28: Prevalent Cases of Obstructive Sleep Apnea in Spain (2016-2027)
Table 29: Total Prevalence of Obstructive Sleep Apnea in Adults in Spain (2016-2027)
Table 30: Gender Specific Prevalence of Obstructive Sleep Apnea in Spain (2016-2027)
Table 31: Severity specific Prevalent Cases of Obstructive Sleep Apnea in Spain (2016-2027)
Table 32: Prevalence of Clinical Manifestation of OSA in Adults in Spain (2016-2027)
Table 33: Prevalent Cases of Obstructive Sleep Apnea in the United Kingdom (2016-2027)
Table 34: Total Prevalence of Obstructive Sleep Apnea in Adults the United Kingdom (2016-2027)
Table 35: Gender Specific Prevalence of OSA in the United Kingdom (2016-2027)
Table 36: Severity specific Prevalent Cases of Obstructive Sleep Apnea in the UK (2016-2027)
Table 37: Prevalence of Clinical Manifestation of OSA in Adults in the UK (2016-2027)
Table 38: Age Group Specific Prevalence of Obstructive Sleep Apnea in Japan (2016-2027)
Table 39: Total Prevalence of Obstructive Sleep Apnea in Adults Japan (2016-2027)
Table 40: Gender Specific Prevalence of Obstructive Sleep Apnea in Japan (2016-2027)
Table 41: Severity specific Prevalent Cases of Obstructive Sleep Apnea in Japan (2016-2027)
Table 42: Prevalence of Clinical Manifestation of OSA in Adults in Japan (2016-2027)
Figure 1: Sleep Apnea
Figure 2: Apnea / hypopnea cycle
Figure 3: Pathological relationship between sleep apnea and cardiovascular disease
Figure 4: Risk Factors for Obstructive Sleep Apnea
Figure 5: Clinical algorithm for implementation of clinical practice guidelines.
Figure 6: Prevalent Population of Obstructive Sleep Apnea in the 7MM (2016-2027)
Figure 7: Total Adult OSA Cases in 7MM (2016-2027)
Figure 8: Prevalence of Obstructive Sleep Apnea by Age Group in the United States (2016-2027)
Figure 9: Prevalence of OSA in Adults in the United States (2016-2027)
Figure 10: Gender Specific Prevalence of Obstructive Sleep Apnea in the United States (2016-2027)
Figure 11: Severity-specific Prevalent Cases of Obstructive Sleep Apnea in the United States (2016-2027)
Figure 12: Prevalence of Clinical Manifestation of OSA in Adults in the United States (2016-2027)
Figure 13: Prevalence of Obstructive Sleep Apnea in Germany by Age Group (2016-2027)
Figure 14: Total Prevalence of Obstructive Sleep Apnea in Adults in Germany (2016-2027)
Figure 15: Gender Specific Prevalence of Obstructive Sleep Apnea in Adults in Germany (2016-2027)
Figure 16: Severity specific prevalent cases of Obstructive Sleep Apnea in Germany (2016-2027)
Figure 17: Prevalence of Clinical Manifestation of OSA in Adults in Germany (2016-2027)
Figure 18: Prevalence of Obstructive Sleep Apnea in France by Age Group (2016-2027)
Figure 19: Total Prevalence of Obstructive Sleep Apnea in Adults in France (2016-2027)
Figure 20: Gender-specific Prevalent Cases of Obstructive Sleep Apnea in France (2016-2027)
Figure 21: Severity Specific Prevalence of Obstructive Sleep Apnea in France (2016-2027)
Figure 22: Prevalence of Clinical Manifestation of OSA in Adults in Germany (2016-2027)
Figure 23: Prevalence of Obstructive Sleep Apnea by Age Group in Spain (2016-2027)
Figure 24: Total Prevalence of Obstructive Sleep Apnea in Adults in Spain (2016-2027)
Figure 25: Gender Specific Prevalence of Obstructive Sleep Apnea in Spain (2016-2027)
Figure 26: Severity specific Prevalent Cases of Obstructive Sleep Apnea in Spain (2016-2027)
Figure 27: Prevalence of Clinical Manifestation of OSA in Adults in Spain (2016-2027)
Figure 28: Prevalent Cases of Obstructive Sleep Apnea in the United Kingdom (2016-2027)
Figure 29: Total Prevalence of Obstructive Sleep Apnea in Adults the United Kingdom (2016-2027)
Figure 30: Gender Specific Prevalence of OSA in the United Kingdom (2016-2027)
Figure 31: Severity specific Prevalent Cases of Obstructive Sleep Apnea in the United Kingdom (2016-2027)
Figure 32: Prevalence of Clinical Manifestation of OSA in Adults in the UK (2016-2027)
Figure 33: Age Group Specific Prevalence of Obstructive Sleep Apnea in Japan (2016-2027)
Figure 34: Total Prevalence of Obstructive Sleep Apnea in Adults Japan (2016-2027)
Figure 35: Gender Specific Prevalence of Obstructive Sleep Apnea in Japan (2016-2027)
Figure 36:: Severity specific Prevalent Cases of Obstructive Sleep Apnea in Japan (2016-2027)
Figure 37: Prevalence of Clinical Manifestation of OSA in Adults in Japan(2016-2027)
Figure 38: Unmet Needs for Obstructive Sleep Apnea
Figure 55: Market Drivers
Figure 56:Market Barriers

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report